It is a financial services private limited company based in New Delhi, Delhi, India, established in 1988.
1988 | New Delhi, Delhi, India | ActiveRanpharm Investments Private Limited, a active private limited company, was established on 11 March 1988 in New Delhi, Delhi, India. Engaging in diversified financial services within the financial and insurance service sector, it holds CIN: U74899DL1988PTC030922. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Nitash Desai Luthra (Director), Freyan Jamshed Desai (Director), Rustom Jamshed Desai (Director). Past directors included Raghbir Singh, Rustom Jamshed Desai. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 229, First Floor, Dlf South Court Plot A-1, District Centre, Saket, New Delhi, Delhi, 110017.
U74899DL1988PTC030922
030922
11 March 1988
₹1.75 Cr
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ranpharm Investments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitash Desai Luthra | Director | 23 Dec 1992 | Current |
| Freyan Jamshed Desai | Director | 09 Dec 1989 | Current |
| Rustom Jamshed Desai | Director | 01 Apr 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ranpharm Investments Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 93.22% decrease. The company also saw a substantial improvement in profitability, with a 29.61% increase in profit. The company's net worth dipped by a decrease of 1.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ranpharm Investments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ranpharm Investments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ranpharm Investments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranpharm Investments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ranpharm Investments Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Ranpharm Investments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Rustom Jamshed Desai was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 8 months . was documented.
The activity Nitash Desai Luthra was appointed as a Director was appointed as a Director on 23 Dec 1992 & has been associated with this company since 32 years 11 months . was completed.
The activity Freyan Jamshed Desai was appointed as a Director was appointed as a Director on 09 Dec 1989 & has been associated with this company since 35 years 11 months . was completed.
The activity Ranpharm Investments Private Limited was registered on 11 Mar 1988 with Roc Delhi & aged 37 years 8 months as per MCA records. was completed.
The CIN of Ranpharm Investments Private Limited is U74899DL1988PTC030922.
Ranpharm Investments Private Limited is headquartered at 229, First Floor, Dlf South Court Plot A-1, District Centre, Saket, New Delhi, Delhi, 110017.
Ranpharm Investments Private Limited was incorporated on 11 March 1988.
The current directors of Ranpharm Investments Private Limited are
The primary industry of Ranpharm Investments Private Limited is Financial And Insurance Service.
Ranpharm Investments Private Limited is unlisted.
The authorized capital of Ranpharm Investments Private Limited is ₹1.75 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Ranpharm Investments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX